Reduced Stroke Risk among Patients with Atrial Fibrillation Receiving Chinese Herbal Medicines Treatment: Analysis of Domestic Data in Taiwan

2020 Jun 09   Medicina   Zheng LC, Livneh H, Chen WJ, Lin MC, Lu MC, Yeh CC, et al.

The findings of the present study suggest that adding CHMs to conventional therapy could decrease subsequent stroke risk for AF patients. It is also suggested that prospective randomized trials are needed to further clarify if the detected association revealed in this study supports a causal link, and to identify the specific CHMs that may be beneficial to AF patients.

Cohort Study Atrial Fibrillation
Submitted by Jinnan C. 4 Oct 2022 - Added by Jinnan C. 4 Oct 2022

Insights & Discussion

Adding Chinese herbal medicines to conventional therapy could decrease subsequent stroke risk for atrial fibrillation patients.

From a nationwide database, 11,456 AF patients aged ≧ 20 years between 1998 and 2007 were identified. Afterwards, we enrolled 2670 CHMs users and randomly selected 2670 non-CHMs users using the propensity score method. The occurrence of stroke was recorded until the end of 2012.

Within the follow-up period, 671 CHMs users and 900 non-CHMs users developed stroke, with incidence rates of 33.02 and 45.46 per 1000 person-years, respectively. CHMs use was associated with a 30% lower stroke risk, especially for those receiving CHMs for over two years.

— Jinnan C. 4 Oct 2022
Sign In

Sign in to comment on this article.

Sign In Create Account